Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Modular Bioprocessing Platform (MBP)

The MBP system from Syntegon subsidiary Pharmatec features a prefabricated integrated cleanroom design with all peripheral technology outside the cleanroom in technical skids.

Developed specifically to deliver on the benefits of modularization, the new Pharmatec modular bioprocessing platform (MBP) features a design with all peripheral technology outside the cleanroom.
Developed specifically to deliver on the benefits of modularization, the new Pharmatec modular bioprocessing platform (MBP) features a design with all peripheral technology outside the cleanroom.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The Syntegon subsidiary Pharmatec is launching its new Modular Bioprocessing Platform (MBP). Developed to address pressing current challenges in biopharmaceutical production, the MBP is a flexible, fully integrated, and automated solution for biologic drug substances. The platform can be configured for a full range of microbial and mammalian cell culture applications including proteins and peptides, oligonucleotides and plasmid DNA, as well as whole or sub-unit recombinant vaccines. The modular design aims to deliver shorter lead times and lower costs without compromising on functionality or the accustomed ‘made in Germany’ quality.

Shorter times to production

Integral to time to market in today’s biopharmaceutical industry, the need for enhanced functionality and compliance in manufacturing operations has never been greater. “Biopharma companies are under intense pressure to bring increasingly sophisticated production capacity online in ever-shorter timelines,” says Christian Lavarreda, global product manager at Pharmatec.

Featuring a prefabricated integrated cleanroom design with all peripheral technology outside the cleanroom in technical skids, the MBP approach to cell culture offers full functionality off-the-shelf for clinical and commercial production alike. For example, the precise temperature control for all integrated vessels is supplied from the technical area, for a new maintenance concept. The platform also includes seamless interfaces for reusable and single-use ancillary systems, including sampling. Pharmatec, an aseptic processing specialist, included a hygienic design with sealed interfaces for the fermentation system. In addition, the MBP is operator friendly with multiple well-placed HMIs. Recipe configuration, selection, and execution, as well as the monitoring of all critical process parameters, are designed for ease-of-use.

 Efficient scale-up and lifecycle sustainability

Modular hardware and automation frameworks, as implemented in the MBP, are fundamental to the advanced control strategies that are necessary for improved process characterization and successful tech transfer. The scalability of the MBP is highly resource-efficient, facilitating an optimized scale-up from clinical to commercial production. Advanced analytical functions like predictive product quality assessments and comprehensive production line analyses enable biopharma manufacturers to continuously optimize their production processes.

Meeting the highest hygiene, safety, and sustainability standards was a focus during development, which is supported by the integrated and fully automated cleaning in place (CIP) and filter integrity testing (FIT) functionalities. Pharmatec notes it is committed to the sustainability of its equipment along its entire lifecycle and will continuously add new and improved functions and options. The modular concept allows for the addition of functionalities or capacity quickly and efficiently in the future.

Fill out the form below to request more information about Modular Bioprocessing Platform (MBP)
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report